Nagoya, Japan

Kazuhiro Harada

This inventor holds 1 USPTO granted patent. Top assignees: Nagoya University, Sysmex Corporation. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuhiro Harada. Retrieved from https://idiyas.com/inventor/kazuhiro-harada-odwcut0o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazuhiro Harada: Innovator in Cardiovascular Disease Prognosis

Introduction

Kazuhiro Harada is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of cardiovascular health through his innovative methods. His work focuses on predicting the severity and prognosis of cardiovascular diseases, which is crucial for timely medical intervention.

Latest Patents

Kazuhiro Harada holds a patent for a method that predicts the severity and prognosis of cardiovascular disease. This method involves acquiring a value related to VEGF-A from a subject. The value can be a measured total VEGF-A in a blood sample or a ratio of VEGF-Ab to total VEGF-A. This innovative approach aids in assessing the prognosis of myocardial infarction and the severity of coronary artery disease.

Career Highlights

Throughout his career, Kazuhiro Harada has worked with prestigious institutions, including Nagoya University and Sysmex Corporation. His experience in these organizations has allowed him to develop and refine his innovative methods in cardiovascular research.

Collaborations

Kazuhiro has collaborated with notable colleagues such as Ryosuke Kikuchi and Yohei Shibata. Their combined expertise has contributed to advancements in the understanding and treatment of cardiovascular diseases.

Conclusion

Kazuhiro Harada's contributions to cardiovascular health through his patented methods highlight the importance of innovation in medical science. His work continues to pave the way for improved prognostic tools in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…